CAES - A COST-EFFECTIVE POWER OPTION

被引：0
|
作者：
POTTS, RW [1 ]
IOCCA, JM [1 ]
KELSALL, AC [1 ]
机构：
[1] ZEI INC,ANN ARBOR,MI
来源：
ELECTRICAL WORLD | 1983年 / 197卷 / 08期
关键词：
D O I：
暂无
中图分类号：
TM [电工技术]; TN [电子技术、通信技术];
学科分类号：
0808 ; 0809 ;
摘要：
引用
收藏
页码：77 / 80
页数：4
相关论文
共 50 条
  • [21] Symposium on cost-effective steps to fusion power
    Dean, SO
    JOURNAL OF FUSION ENERGY, 1998, 17 (03) : 177 - 182
  • [22] Symposium on Cost-Effective Steps to Fusion Power
    Stephen O. Dean
    Journal of Fusion Energy, 1998, 17 : 177 - 182
  • [23] Towards cost-effective reliability through visualization of the reliability option space
    Feather, MS
    ANNUAL RELIABILITY AND MAINTAINABILITY SYMPOSIUM, 2004 PROCEEDINGS, 2004, : 546 - 552
  • [24] Proactive biological control: A cost-effective management option for invasive pests
    Hoddle, Mark S.
    Mace, Kevi
    Steggall, John
    CALIFORNIA AGRICULTURE, 2018, 72 (03) : 148 - 150
  • [25] IS THE USE OF ESOMEPRAZOLE IN GASTROESOPHAGEAL REFLUX DISEASE A COST-EFFECTIVE OPTION IN POLAND?
    Petryszyn, P.
    Staniak, A.
    VALUE IN HEALTH, 2013, 16 (07) : A498 - A498
  • [26] Surgery: A Cost-Effective Option for Drug-Resistant Epilepsy in China
    Chen, Jianbin
    Lei, Ding
    WORLD NEUROSURGERY, 2014, 82 (1-2) : E375 - E376
  • [27] Is the use of esomeprazole in gastroesophageal reflux disease a cost-effective option in Poland?
    Petryszyn, Pawel
    Staniak, Aleksandra
    Grzegrzolka, Jedrzej
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2016, 5 (02) : 169 - 178
  • [28] Ambulatory Management of Bite Injuries to the Hand: A Safe and Cost-Effective Option
    Haq, Ibrahim I.
    Manku, Bhagat
    Mahon, Andrew
    Langley, Clare
    Samson, Deepak
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)
  • [29] CONTROL OF ASCARIS INFECTION BY CHEMOTHERAPY - WHICH IS THE MOST COST-EFFECTIVE OPTION
    GUYATT, HL
    CHAN, MS
    MEDLEY, GF
    BUNDY, DAP
    TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE, 1995, 89 (01) : 16 - 20
  • [30] OCRELIZUMAB IS A COST-EFFECTIVE OPTION FOR RELAPSING MULTIPLE SCLEROSIS PATIENTS, IN IRAN
    Ayati, N.
    Ma, Sahraian
    Taheri, S.
    Nikfar, S.
    VALUE IN HEALTH, 2019, 22 : S744 - S745
12345